ESMO 2012: Industry Sponsored Satellite Symposia

Click on the links below to access the satellite invitations. The following satellites are listed in alphabetical order (by company).

Achieving new standards in bone metastases treatment

Amegen50x50

Personalising medicine for GI cancers

Amegen-pm50x50

HER2-targeted therapy for metastatic breast cancer: A multidisciplinary approach

Click here to view the satellite invitation

New evidence, new standards? Redefining treatment selection in mRCC

Click here to view the satellite invitation

Managing GI malignancies with targeted therapeutics; focus on NET, GIST, and HCC

Click here to view the satellite invitation

Targeting advanced breast cancer at the molecular level – translating emerging data into clinical practice

Click here to view the satellite invitation

Timely interventions in metastatic RCC: Treatment choices in an intricate landscape

Click here to view the satellite invitation

Beyond convention: New perspectives in NSCLC

Click here to view the satellite invitation

Clinical advances in HER2-positive breast cancer: Overcoming challenges with patients in mind

Click here to view the satellite invitation

Individualised treatment strategies to maximise survival in mCRC

Click here to view the satellite invitation

Integrating bevacizumab into clinical practice in ovarian cancer

Click here to view the satellite invitation

Personalising therapy in metastatic melanoma

Click here to view the satellite invitation

Turning today’s challenges in tomorrow’s success

Click here to view the satellite invitation


Please note: The European Society for Medical Oncology (ESMO) does not endorse any of the companies, or their products/services, that have sponsored these links.